Start-up fighting gum disease gets $14m to fund human trials
SYDNEY: CSL-backed biotech company Denteric has closed a $14 million funding round, enabling it to
SYDNEY: CSL-backed biotech company Denteric has closed a $14 million funding round, enabling it to